Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Technology acquisition broadens and accelerates ICAgen's R&D programs

Oct. 20, 1999

New drug discovery collaboration with Organon announced by Pharmacopeia

Oct. 20, 1999

Glaxo Wellcome makes strides in genetic research

Oct. 20, 1999

Two new photoactivatable, biotin-labeled verapamil analogues useful for studies on P-170

Oct. 13, 1999

Enzo Biochem's HGTV43 achieves high levels of gene delivery to human cells

Oct. 12, 1999

Synthesis and activity of potent, selective sigma1 ligands reported by Taisho

Oct. 8, 1999

Aventis R&T expands drug discovery collaboration with Nanogen

Oct. 5, 1999

Incyte and Schering expand agreement

Oct. 5, 1999

Isis and RPR establish collaboration for antisense target validation

Oct. 4, 1999

ImmGenics and Genzyme enter collaboration agreement to use SLAM technology

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...